What is Xtetic?
Xtetic operates as a premier digital marketplace and supply chain authority for professional aestheticians, specializing in pharmaceutical-grade skincare solutions. With a legacy spanning over two decades, the company serves as an official conduit for elite brands such as mesoestetic, Innoaesthetic, and Surplexion. By providing practitioners with advanced tools, including cutting-edge exosome therapies, Xtetic empowers clinical professionals to deliver superior patient outcomes. The company's business model bridges the gap between high-end medical manufacturers and the rapidly evolving aesthetics industry, ensuring that practitioners have reliable access to the latest innovations in dermatological science.
How much funding has Xtetic raised?
Xtetic has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Xtetic
PPP
Public-Private Partnership
What's next for Xtetic?
With the successful acquisition of this latest financing, Xtetic is entering a critical phase of operational scaling. The strategic allocation of these funds will likely focus on enhancing the company's digital infrastructure and strengthening its logistics network to meet the growing demand for professional-grade skincare products. As the aesthetics market continues to shift toward more sophisticated, science-backed treatments, Xtetic is well-positioned to leverage its established supplier relationships to capture additional market share. Future growth initiatives will likely prioritize the integration of new therapeutic categories and the expansion of its professional education programs, further cementing its role as a cornerstone of the aesthetic skincare revolution.
See full Xtetic company page
